logo

For the Inventor, By the Inventor

Millington, NJ, United States of America

Nicholas J Murgolo

This inventor holds 15 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp.. Active years: 1997-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas J Murgolo. Retrieved from https://idiyas.com/inventor/nicholas-j-murgolo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 53.3

 

Average Co-Inventor Count = 4.8

ph-index = 7

Forward Citations = 253(Granted Patents)


Company Filing History:

goldMedal13 out of 1,829 
 
Schering Corporation
 patents
silverMedal2 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents

Years Active: 1997-2015

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 9181632 - C.difficile toxin B CROP domain peptides, antibodies and complexes thereof (2015-11-10),
2. 9089522 - Method of reducing total cholesterol level by administering matrilin-2 polypeptide (2015-07-28),
3. 8133980 - Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereof (2012-03-13),
4. 7812126 - DIRS1 polypeptides (2010-10-12),
5. 7807390 - G-protein coupled receptor ligands and methods (2010-10-05),
6. 7342103 - DIRS1 antibodies (2008-03-11),
7. 7338772 - G-protein coupled receptor ligands and methods (2008-03-04),
8. 7135556 - NPC1L1 (NPC3) and methods of use thereof (2006-11-14),
9. 6586228 - Polynucleotides encoding DIRS1 (2003-07-01),
10. 6451982 - Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 (2002-09-17),
11. 6056957 - Humanized monoclonal antibodies against human interleukin-5 (2000-05-02),
12. 5863537 - Humanized monoclonal antibodies against human interleukin-4 (1999-01-26),
13. 5770403 - Cloning and exprssion of humanized monoclonal antibodies against human (1998-06-23),
14. 5705154 - Humanized monoclonal antibodies against human interleukin-4 (1998-01-06),
15. 5597710 - Humanized monoclonal antibodies against human interleukin-4 (1997-01-28),

Title: Innovations and Contributions of Nicholas J Murgolo

Introduction

Nicholas J Murgolo is a prominent inventor based in Millington, NJ (US), known for his significant contributions to the field of biotechnology. With a total of 15 patents to his name, Murgolo has made remarkable advancements in medical science, particularly in the development of therapeutic polypeptides and antibodies.

Latest Patents

Among his latest patents is the invention related to C.difficile toxin B CROP domain peptides, antibodies, and complexes thereof. This invention provides polypeptide domains of toxin B (B1, B2, B3, B4) and complexes between the polypeptides and antibodies that bind specifically to the polypeptide. Additionally, methods of using these polypeptides to generate antibodies are also included. Another notable patent involves a method of reducing total cholesterol levels by administering matrilin-2 polypeptide. This invention outlines methods and compositions for treating lipid disorders by administering a polypeptide that inhibits PCSK9, along with a novel method for identifying polypeptides that interact with PCSK9.

Career Highlights

Throughout his career, Murgolo has worked with esteemed companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His work in these organizations has contributed to the advancement of pharmaceutical research and development.

Collaborations

Murgolo has collaborated with notable colleagues, including Stephen Tindall and Barbara Dalie, enhancing the innovation process through teamwork and shared expertise.

Conclusion

Nicholas J Murgolo's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to impact medical science positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…